Wird geladen...
Eradication of Hepatitis C Virus Is Associated With Reduction in Hematologic Malignancies: Major Differences Between Interferon and Direct‐Acting Antivirals
It is unclear whether eradication of hepatitis C virus (HCV) leads to a reduction in the risk of hematologic malignancies. We aimed to determine the impact of sustained virologic response (SVR) induced by either direct‐acting antivirals (DAAs) or interferon (IFN) on the risk of hematologic malignanc...
Gespeichert in:
Veröffentlicht in: | Hepatol Commun |
---|---|
Hauptverfasser: | , , , |
Format: | Artigo |
Sprache: | Inglês |
Veröffentlicht: |
John Wiley and Sons Inc.
2019
|
Schlagworte: | |
Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6671776/ https://ncbi.nlm.nih.gov/pubmed/31388632 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep4.1389 |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|